ChemicalBook > CAS DataBase List > Ifetroban

Ifetroban

Product Name
Ifetroban
CAS No.
143443-90-7
Chemical Name
Ifetroban
Synonyms
BMS180291;Ifetroban;BMS-180291;BMS 180291-02;Benzenepropanoic acid, 2-[[(1S,2R,3S,4R)-3-[4-[(pentylamino)carbonyl]-2-oxazolyl]-7-oxabicyclo[2.2.1]hept-2-yl]methyl]-
CBNumber
CB91116567
Molecular Formula
C25H32N2O5
Formula Weight
440.537
MOL File
143443-90-7.mol
More
Less

Ifetroban Property

form 
Solid
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
BRS0000378
Product name
IFETROBAN
Purity
95.00%
Packaging
5MG
Price
$499.48
Updated
2021/12/16
More
Less

Ifetroban Chemical Properties,Usage,Production

Uses

Antithrombotic.

Definition

ChEBI: Ifetroban is a monocarboxylic acid and a member of benzenes.

in vivo

Ifetroban (50 mg/kg/d; p.o.; 2 d prior to, through 28 d after tumor injection) decreases hematogenous metastasis of multiple cancer types without in mice model[2].
Ifetroban (50 mg/kg/d; p.o.; 12 d) does not affect primary tumor growth but decreases tumor vessels in mice with 4T1 (mouse mammary cancer)[2].
Ifetroban (BMS 180,291; 1 and 3 mg/kg, p.o.) inhibits aggregation and antagonizes TP-receptor in monekys. Ifetroban (3 mg/kg, i.v.) causes only marginal and transient hemodynamic effects in anesthetized African green monkeys[3].

Animal Model:Athymic (nu/nu) Balb/C female mice injected with tumor cells: 4T1 (mouse mammary cancer), MDA-MB-231 (human breast cancer), MiaPaCa2 (human pancreatic cancer), and A549 (human lung cancer) model[2]
Dosage:50 mg/kg; via 25 μL vehicle (4% sucrose in sterile water)
Administration:Oral gavage; pretreated before 2 days and treated 28 days later
Result:Decreased the percentage of mice harboring MDA-MB-231 lung metastases from 90% to 20%, and mice with A549 lung metastases from 60% to 10%.

IC 50

TXA2/TP

Ifetroban Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Ifetroban Suppliers

Jiangsu Magic Biotechnology Co., Ltd
Tel
13921770081
Email
svp01@magicbiotech.cn
Country
China
ProdList
500
Advantage
58
Zhengzhou Runkai Pharmaceutical Technology Co., Ltd
Tel
191-19137044811 19137644811
Email
3649307081@qq.com
Country
China
ProdList
500
Advantage
58
Guangzhou Brand-new Changshi Pharmaceutical Biotechnology Co., Ltd
Tel
19066311943
Email
815989315@qq.com
Country
China
ProdList
797
Advantage
58

143443-90-7, IfetrobanRelated Search:


  • Ifetroban
  • Benzenepropanoic acid, 2-[[(1S,2R,3S,4R)-3-[4-[(pentylamino)carbonyl]-2-oxazolyl]-7-oxabicyclo[2.2.1]hept-2-yl]methyl]-
  • BMS 180291-02
  • BMS180291
  • BMS-180291
  • 143443-90-7